Literature DB >> 30062515

Quantification of desmosine and isodesmosine using MALDI-ion trap tandem mass spectrometry.

Pratikkumar Rathod1,2, Manjeet Kaur1, Hsin-Pin Ho1, Marissa E Louis1, Basant Dhital3, Philip Durlik4, Gregory S Boutis3,4, Kevin J Mark5, Jong I Lee1, Emmanuel J Chang6,7,8.   

Abstract

Desmosine (Des) and isodesmosine (Isodes), cross-linking amino acids in the biomolecule elastin, may be used as biomarkers for various pathological conditions associated with elastin degradation. The current study presents a novel approach to quantify Des and Isodes using matrix-assisted laser desorption ionization (MALDI)-tandem mass spectrometry (MS2) in a linear ion trap coupled to a vacuum MALDI source. MALDI-MS2 analyses of Des and Isodes are performed using stable-isotope-labeled desmosine d4 (labeled-Des) as an internal standard in different biological fluids, such as urine and serum. The method demonstrated linearity over two orders of magnitude with a detection limit of 0.02 ng/μL in both urine and serum without enrichment prior to mass spectrometry, and relative standard deviation of < 5%. The method is used to evaluate the time-dependent degradation of Des upon UV irradiation (254 nm) and found to be consistent with quantification by 1H NMR. This is the first characterized MALDI-MS2 method for quantification of Des and Isodes and illustrates the potential of MALDI-ion trap MS2 for effective quantification of biomolecules. The reported method represents improvement over current liquid chromatography-based methods with respect to analysis time and solvent consumption, while maintaining similar analytical characteristics. Graphical abstract ᅟ.

Entities:  

Keywords:  Desmosine; Isodesmosine; MALDI-MS; NMR; Quantification; UV radiation

Mesh:

Substances:

Year:  2018        PMID: 30062515      PMCID: PMC6133720          DOI: 10.1007/s00216-018-1288-z

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  42 in total

1.  Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry.

Authors:  Osama Albarbarawi; Alun Barton; Zhaosheng Lin; Eddie Takahashi; Ajay Buddharaju; Jeffrey Brady; Douglas Miller; Colin N A Palmer; Jeffrey T-J Huang
Journal:  Anal Chem       Date:  2010-05-01       Impact factor: 6.986

2.  Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases.

Authors:  Hideyuki Umeda; Masanori Aikawa; Peter Libby
Journal:  Biochem Biophys Res Commun       Date:  2011-06-25       Impact factor: 3.575

3.  Development of a robust LC-MS/MS method for determination of desmosine and isodesmosine in human urine.

Authors:  Kohei Shiraishi; Kazue Matsuzaki; Akinori Matsumoto; Yuuki Hashimoto; Kazuhiko Iba
Journal:  J Oleo Sci       Date:  2010       Impact factor: 1.601

4.  Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.

Authors:  Theresa A Laguna; Brandie D Wagner; Barry Starcher; Heidi K Luckey Tarro; Shelley A Mann; Scott D Sagel; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2012-03-19

5.  Higher urine desmosine levels are associated with mortality in patients with acute lung injury.

Authors:  Dana E McClintock; Barry Starcher; Mark D Eisner; B Taylor Thompson; Doug L Hayden; Gwynne D Church; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-05-12       Impact factor: 5.464

6.  Elastin and collagen degradation products in urine of patients with cystic fibrosis.

Authors:  P J Stone; M W Konstan; M Berger; H L Dorkin; C Franzblau; G L Snider
Journal:  Am J Respir Crit Care Med       Date:  1995-07       Impact factor: 21.405

7.  The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum.

Authors:  Shuren Ma; Seymour Lieberman; Gerard M Turino; Yong Y Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-16       Impact factor: 11.205

8.  Determination of desmosines in elastin-related skin disorders by isocratic high-performance liquid chromatography.

Authors:  E Schwartz; F A Cruickshank; M Lebwohl
Journal:  Exp Mol Pathol       Date:  1990-02       Impact factor: 3.362

9.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease.

Authors:  Jeffrey T J Huang; Rekha Chaudhuri; Osama Albarbarawi; Alun Barton; Christal Grierson; Petra Rauchhaus; Christopher J Weir; Martina Messow; Nicola Stevens; Charles McSharry; Giora Feuerstein; Somnath Mukhopadhyay; Jeffrey Brady; Colin N A Palmer; Douglas Miller; Neil C Thomson
Journal:  Thorax       Date:  2012-01-16       Impact factor: 9.139

View more
  2 in total

1.  Modulation of Photoaging-Induced Cutaneous Elastin: Evaluation of Gene and Protein Expression of Markers Related to Elastogenesis Under Different Photoexposure Conditions.

Authors:  Ana Cristina Weihermann; Camila Miranda de Carvalho; Desirée Cigaran Schuck; Bruna Bastos Swinka; Rodrigo Makowiecky Stuart; Ruth Maria Graf; Márcio Lorencini; Carla Abdo Brohem
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-14

2.  Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.

Authors:  Jing Liu; Sheng Liu; Zhao Zhang; Xuejun Lee; Wenxuan Wu; Zhanlian Huang; Ziying Lei; Wenxiong Xu; Dabiao Chen; Xing Wu; Yang Guo; Liang Peng; Bingliang Lin; Yutian Chong; Xiangyu Mou; Mang Shi; Ping Lan; Tao Chen; Wenjing Zhao; Zhiliang Gao
Journal:  Synth Syst Biotechnol       Date:  2021-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.